Cerebrospinal fluid-infiltrating CD4+ T cells recognize Borrelia burgdorferi lysine-enriched protein domains and central nervous system autoantigens in early lyme encephalitis

Infection and Immunity

Volumn 75, Issue 1, 2007, Pages 243-251

  Lünemann, Jan D ^a,e   Gelderblom, Harald ^a,f   Sospedra, Mireia ^a,b   Quandt, Jacqueline A ^a   Pinilla, Clemencia ^c   Marques, Adriana ^d   Martin, Roland ^a,b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e ROCKEFELLER UNIVERSITY   (United States)

^f HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; AMINO ACID; AUTOANTIGEN; CD4 ANTIGEN; CYTOKINE; EPITOPE; GAMMA INTERFERON; GLUCURONOSYLTRANSFERASE; HEAT SHOCK PROTEIN 90; INTERLEUKIN 4; LYSINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MYELIN PROTEIN; PEPTIDE; RIBOSOME PROTEIN; STRESS ACTIVATED PROTEIN KINASE 1; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; BORRELIA BURGDORFERI; CASE REPORT; CD4+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; CYTOKINE PRODUCTION; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYME DISEASE; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; WESTERN BLOTTING;

2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; ANTIGENS, BACTERIAL; AUTOANTIGENS; BORRELIA BURGDORFERI; CD4-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLONE CELLS; CROSS REACTIONS; EPITOPES, T-LYMPHOCYTE; FLOW CYTOMETRY; HSP90 HEAT-SHOCK PROTEINS; HUMANS; LYME NEUROBORRELIOSIS; LYSINE; MALE; MIDDLE AGED; PEPTIDE LIBRARY;

EID: 33846006928     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01110-06     Document Type: Article

References (54)

1. Aguero-Rosenfeld, M. E., J. Nowakowski, S. Bittker, D. Cooper, R. B. Nadelman, and G. P. Wormser. 1996. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J. Clin. Microbiol. 34:1-9.
2. + T helper 1 cells facilitate regression of murine Lyme carditis. Infect. Immun. 69:5264-5269.
3. Carroll, J. A., C. F. Garon, and T. G. Schwan. 1999. Effects of environmental pH on membrane proteins in Borrelia burgdorferi. Infect. Immun. 67:3181-3187.
4. Coyle, P. K., and S. E. Schutzer. 2002. Neurologic aspects of Lyme disease. Med. Clin. N. Am. 86:261-284.
5. 4a. Deak, M., A. D. Clifton, L. M. Lucocq, and D. R. Alessi. 1998. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 17:4426-4441.
6. Embers, M. E., R. Ramamoorthy, and M. T. Philipp. 2004. Survival strategies of Borrelia burgdorferi, the etiologic agent of Lyme disease. Microbes Infect. 6:312-318.
7. Fleischer, B., and IL W. Kreth. 1983. Clonal analysis of HLA-restricted virus-specific cytotoxic T lymphocytes from cerebrospinal fluid in mumps meningitis. J. Immunol. 130:2187-2190.
8. 6a. C. M. Fraser, S. Casjens, W. M. Huang, G. G. Sutton, R. Clayton, R. Lathigra, O. White, K. A. Ketchum, R. Dodson, E. K. Hickey, M. Gwinn, B. Dougherty, J. F. Tomb, R. D. Fleischmann, D. Richardson, J. Peterson, A. R. Kerlavage, J. Quackenbush, S. Salzberg, M. Hanson, R. van Vugt, N. Palmer, M. D. Adams, J. Gocayne, J. Weidman, T. Utterback, L. Watthey, L. McDonald, P. Artiach, C. Bowman, S. Garland, C. Fuji, M. D. Cotton, K. Horst, K. Roberts, B. Hatch, H. O. Smith, and J. C. Venter. 1997. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 290: 580-586.
9. Giunti, D., G. Borsellino, R. Benelli, M. Marchese, E. Capello, M. T. Valle, E. Pedemonte, D. Noonan, A. Albini, G. Bernardi, G. L. Mancardi, L. Battistini, and A. Uccelli. 2003. Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. J. Leukoc. Biol. 73:584-590.
10. Gross, D. M., T. Forsthuber, M. Tary-Lehmann, C. Etling, K. Ito, Z. A. Nagy, J. A. Field, A. C. Steere, and B. T. Huber. 1998. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 281: 703-706.
11. Halperin, J. J. 2005. Central nervous system Lyme disease. Curr. Neurol. Neurosci. Rep. 5:446-452.
12. Halperin, J. J. 1997. Neuroborreliosis: central nervous system involvement. Semin. Neurol. 17:19-24.
13. Hemmer, B., B. T. Fleckenstein, M. Vergelli, G. Jung, H. McFarland, R. Martin, and K. H. Wiesmuller. 1997. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J. Exp. Med. 185:1651-1659.
14. Hemmer, B., B. Gran, Y. Zhao, A. Marques, J. Pascal, A. Tzou, T. Kondo, I. Cortese, B. Bielekova, S. E. Straus, H. F. McFarland, R. Houghten, R. Simon, C. Pinilla, and R. Martin. 1999. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat. Med. 5:1375-1382.
15. Hemmer, B., C. Pinilla, B. Gran, M. Vergelli, N. Ling, P. Conlon, H. F. McFarland, R. Houghten, and R. Martin. 2000. Contribution of individual amino acids within MHC molecule or antigenic peptide to TCR ligand potency. J. Immunol. 164:861-871.
16. Hemmer, B., M. Vergelli, B. Gran, N. Ling, P. Conlon, C. Pinilla, R. Houghten, H. F. McFarland, and R. Martin. 1998. Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology. J. Immunol. 160:3631-3636.
17. Houghten, R. A. 1985. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc. Natl. Acad. Sci. USA 82:5131-5135.
18. Jacobsen, M., D. Zhou, S. Cepok, S. Nessler, M. Happel, S. Stei, B. Wilske, N. Sommer, and B. Hemmer. 2003. Clonal accumulation of activated CD8+ T cells in the central nervous system during the early phase of neuroborreliosis. J. Infect. Dis. 187:963-973.
19. Kaiser, R. 1998. Neuroborreliosis. J. Neurol. 245:247-255.
20. Keane-Myers, A., and S. P. Nickell. 1995. Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice. J. Immunol. 155: 2020-2028.
21. Keane-Myers, A., and S. P. Nickell. 1995. T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice. J. Immunol. 154:1770-1776.
22. Kersh, G. J., and P. M. Allen. 1996. Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands. J. Exp. Med. 184:1259-1268.
23. Kivisakk, P., D. J. Mahad, M. K. Callahan, C. Trebst, B. Tucky, T. Wei, L. Wu, E. S. Baekkevold, H. Lassmann, S. M. Staugaitis, J. J. Campbell, and R. M. Ransohoff. 2003. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc. Natl. Acad. Sci. USA 100:8389-8394.
24. 21a. Kurihara, T., Y. Takahashi, A. Nishiyama, and T. Kumanishi. 1988. cDNA cloning and amino acid sequence of human brain 2′,3′- cyclic-nucleotide 3′-phosphodiesterase. Biochem. Biophys. Res. Commun. 152:837-842.
25. Lunemann, J. D., S. Zarmas, S. Priem, J. Franz, R. Zschenderlein, E. Aberer, R. Klein, L. Schouls, G. R. Burmester, and A. Krause. 2001. Rapid typing of Borrelia burgdorferi sensu lato species in specimens from patients with different manifestations of Lyme borreliosis. J. Clin. Microbiol. 39: 1130-1133.
26. Martin, R., B. Gran, Y. Zhao, S. Markovic-Plese, B. Bielekova, A. Marques, M. H. Sung, B. Hemmer, R. Simon, H. F. McFarland, and C. Pinilla. 2001. Molecular mimicry and antigen-specific T cell responses in multiple sclerosis and chronic CNS Lyme disease. J. Autoimmun. 16:187-192.
27. Martin, R., P. Marquardt, S. O'Shea, M. Borkenstein, and H. W. Kreth. 1989. Virus-specific and autoreactive T cell lines isolated from cerebrospinal fluid of a patient with chronic rubella panencephalitis. J. Neuroimmunol. 23:1-10.
28. Martin, R., J. Ortlauf, V. Sticht-Groh, U. Bogdahn, S. F. Goldmann, and H. G. Mertens. 1988. Borrelia burgdorferi-specific and autoreactive T-cell lines from cerebrospinal fluid in Lyme radiculomyelitis. Ann. Neurol. 24: 509-516.
29. Mason, D. 1998. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today 19:395-404.
30. Matyniak, J. E., and S. L. Reiner. 1995. T helper phenotype and genetic susceptibility in experimental Lyme disease. J. Exp. Med. 181:1251-1254.
31. Morris-Downes, M. M., K. McCormack, D. Baker, D. Sivaprasad, J. Natkunarajah, and S. Amor. 2002. Encephalitogenic and immunogenic potential of myelin-associated glycoprotein (MAG), oligodendrocyte-specific glycoprotein (OSP) and 2′,3′-cyclic nucleotide 3 -phosphodiesterase (CNPase) in ABH and SJL mice. J. Neuroimmunol. 122:20-33.
32. Muraro, P. A., M. Kalbus, G. Afshar, H. F. McFarland, and R. Martin. 2002. T cell response to 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in multiple sclerosis patients. J. Neuroimmunol. 130:233-242.
33. Pachner, A. R., D. Dail, Y. Bai, M. Sondey, L. Pak, K. Narayan, and D. Cadavid. 2004. Genotype determines phenotype in experimental Lyme borreliosis. Ann. Neurol. 56:361-370.
34. Pachner, A. R., H. Gelderblom, and D. Cadavid. 2001. The rhesus model of Lyme neuroborreliosis. Immunol. Rev. 183:186-204.
35. Pfister, H. W., V. Preac-Mursic, B. Wilske, K. M. Einhaupl, and K. Weinberger. 1989. Latent Lyme neuroborreliosis: presence of Borrelia burgdorferi in the cerebrospinal fluid without concurrent inflammatory signs. Neurology 39:1118-1120.
36. Philipp, M. T., and B. J. Johnson. 1994. Animal models of Lyme disease: pathogenesis and immunoprophylaxis. Trends Microbiol. 2:431-437.
37. Pinilla, C., J. R. Appel, P. Blanc, and R. A. Houghten. 1992. Rapid identification of high affinity peptide ligands using positional scanning synthetic peptide combinatorial libraries. BioTechniques 13:901-905.
38. Pinilla, C., J. R. Appel, and R. A. Houghten. 1994. Investigation of antigenantibody interactions using a soluble, non-support-bound synthetic decapeptide library composed of four trillion (4 × 10(12) sequences. Biochem. J. 301:847-853.
39. Pohl-Koppe, A., K. E. Balashov, A. C. Steere, E. L. Logigian, and D. A. Hafler. 1998. Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection. J. Immunol. 160:1804-1810.
40. Ramamoorthy, R., L. Povinelli, and M. T. Philipp. 1996. Molecular characterization, genomic arrangement, and expression of bmpD, a new member of the bmp class of genes encoding membrane proteins of Borrelia burgdorferi. Infect. Immun. 64:1259-1264.
41. Rosener, M., P. A. Muraro, A. Riethmuller, M. Kaibus, G. Sappler, R. J. Thompson, R. Lichtenfels, N. Sommer, H. F. McFarland, and R. Martin. 1997. 2′,3′-Cyclic nucleotide 3′-phosphodiesterase: a novel candidate autoantigen in demyelinating diseases. J. Neuroimmunol. 75:28-34.
42. Rupprecht, T. A., V. Koedel, B. Muhlberger, B. Wilske, A. Fontana, and H. W. Pfister. 2005. CXCL11 is involved in leucocyte recruitment to the central nervous system in neuroborreliosis. J. Neurol. 252:820-823.
43. Rupprecht, T. A., H. W. Pfister, B. Angele, S. Kastenbauer, B. Wilske, and U. Koedel. 2005. The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurology 65:448-450.
44. Schwan, T. G., J. Piesman, W. T. Golde, M. C. Dolan, and P. A. Rosa. 1995. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Natl. Acad. Sci. USA 92:2909-2913.
45. Sigal, L. H. 1997. Immunologic mechanisms in Lyme neuroborreliosis: the potential role of autoimmunity and molecular mimicry. Semin. Neurol. 17: 63-68.
46. Sospedra, M., Y. Zhao, H. Zur Hausen, P. A. Muraro, C. Hamashin, E. M. de Villiers, C. Pinilla, and R. Martin. 2005. Recognition of conserved amino acid motifs of common viruses and its role in autoimmunity. PLoS Pathog. 1:e41.
47. Steere, A. C., J. Coburn, and L. Glickstein. 2004. The emergence of Lyme disease. J. Clin. Investig. 113:1093-1101.
48. Vergelli, M., B. Hemmer, U. Utz, A. Vogt, M. Kaibus, L. Tranquill, P. Conlon, N. Ling, L. Steinman, H. F. McFarland, and R. Martin. 1996. Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99). Eur. J. Immunol. 26:2624-2634.
49. Weber, K., and H. W. Pfister. 1994. Clinical management of Lyme borreliosis. Lancet 343:1017-1020.
50. Wilske, B. 2002. Microbiological diagnosis in Lyme borreliosis. Int. J. Med. Microbiol. 291(Suppl. 33):114-119.
51. Wucherpfennig, K. W., and J. L. Strominger. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695-705.
52. Yssel, H., M. C. Shanafelt, C. Soderberg, P. V. Schneider, J. Anzola, and G. Peltz. 1991. Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J. Exp. Med. 174:593-601.
53. 49a. Zhang, T., P. Haws, and Q. Wu. 2004. Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. Genome Res. 14: 79-89.
54. Zhao, Y., B. Gran, C. Pinilla, S. Markovic-Plese, B. Hemmer, A. Tzou, L. W. Whitney, W. E. Biddison, R. Martin, and R. Simon. 2001. Combinatorial peptide libraries and biometric score matrices permit the quantitative analysis of specific and degenerate interactions between clonotypic TCR and MHC peptide ligands. J. Immunol. 167:2130-2141.